Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its novel blood test for oesophageal adenocarcinoma will be presented tomorrow at the 19th ISDE World Congress for Esophageal Diseases.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that its subsidiary OxiDx Pty Ltd has been granted a patent in Japan for its platform technology to measure oxidative stress.
Apiam Animal Health Ltd (ASX:AHX) speaks with ABN Newswire on the recently released financial results, as well as the company's expansion into regional areas with around 20 acquisitions over the last two years.
VGI Health Technology Limited (NSX:VTL) commences divestment of Invictus BioPharma Pty Ltd
Apiam Animal Health Limited (ASX:AHX) today released its full year financial results for the year ended 30 June 2023 (FY23)
Apiam Animal Health Limited (ASX:AHX) will release its financial results for the twelve months ended 30 June 2023 on Monday 28 August 2023.
It has been a pivotal year for Proteomics International Laboratories Ltd (ASX:PIQ), with the signing of a landmark deal to bring our PromarkerD test for diabetic kidney disease to patients in the United States.
